ZVRA - Zevra Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

106.2M

Cash

95.28M

Avg Qtr Burn

-4.802M

Short % of Float

5.84%

Insider Ownership

11.13%

Institutional Own.

17.85%

Qtr Updated

03/31/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
APADAZ (benzhydrocodone and acetaminophen) Details Acute pain	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AZSTARYS (KP415) (serdexmethylphenidate and dexmethylphenidate) Details Attention deficit hyperactivity disorder	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Arimoclomol (Heat-Shock Protein (HSP) amplifier) Details Rare diseases, Rare genetic disease, Methanol poisoning	NDA Resubmission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KP1077, (serdexmethylphenidate, SDX) Details EDS in Idiopathic Hypersomnia Big Mover™ Suspected Mover™ Susp. Mover™	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KP879 (Methylphenidate) Details Stimulant Use Disorder	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KP1077, (serdexmethylphenidate, SDX) Details Sleeping disorder, Narcolepsy	Phase 1 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.